FDA Grants New Indication for Subcutaneous Entyvio
The FDA expanded indication for the subcutaneous administration of vedolizumab to certain patients with Crohn’s disease.
The FDA expanded indication for the subcutaneous administration of vedolizumab to certain patients with Crohn’s disease.
Show Gut Podcast, Ep Microbiome interventions for COPD protection – Apr 30, 2024
Deaths from the majority of cancers are falling globally, but the incidence and mortality from hepatocellular carcinoma (HCC) is increasing in the United Kingdom and…
Objective Liver fibrosis is a prelude to a host of end-stage liver diseases. Hepatic stellate cells (HSCs), switching from a quiescent state to myofibroblasts, are…
In a Healio video exclusive, Wendi LeBrett, MD, winner of the 2023 Healio Social Media Influencer Award, discusses how she uses social media, namely TikTok,…
The 10-year interval between screening colonoscopies “could potentially be extended” to 15 years among patients without a family history of colorectal cancer and negative findings…
The FDA has issued a safety alert warning patients and health care providers of a “rare risk of intrahepatic cholestasis of pregnancy” linked to thiopurine…
Monthly olezarsen 80 mg significantly lowered triglyceride levels and also reduced incidence of acute pancreatitis vs. placebo in patients with familial chylomicronemia syndrome, according to…
The FDA has approved a citrate-free, high-concentration formulation of the interchangeable adalimumab biosimilar Cyltezo to treat multiple chronic inflammatory diseases, according to the manufacturer. As…
Col. Stephen A. Harrison, MD, FAASLD, a key leader in the field of hepatology who dedicated his life to caring for patients and developing treatments…
In a Healio video exclusive, Megan Riehl, PsyD, AGAF, and Kate Scarlata, MPH, RDN, LDN, discuss their new book, “Mind Your Gut,” a comprehensive guide…